Patient-level data from completed clinical studies or electronic health records can be used in the design and analysis of clinical trials. However, these external data can bias the evaluation of the ...
Medical advances in the treatment of cancer have allowed the development of multiple approved treatments and prognostic and predictive biomarkers for many types of cancer. Identifying improved ...
The What Works Clearinghouse (WWC) identifies studies that provide credible and reliable evidence of a given intervention’s effectiveness. Yet there is a high potential for serious estimation bias ...
Predictions are becoming more and more a part of our lives, and they are becoming increasingly useful in medical science as the science evolves. Increased understanding of disease and its treatments ...
The complete findings of the RCT-DUPLICATE demonstration project are published today in JAMA. This three-year initiative tested whether researchers asking clinical questions in real-world data ...
CHICAGO – Loxo Oncology Inc.'s announcement that it will seek tissue-agnostic approval for larotrectinib (LOXO-101) based on data that were presented at this year's ASCO meeting came just weeks after ...
Subjective cognition in chimeric antigen receptor T-cell therapy recipients. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results